1/1 RegenMD

RegenMD         Smed454 dataset: unravelling the transcriptome of Schmidtea mediterranea December 31, 2010 at 1:05 PM   Freshwater planarians are an attractive model for regeneration and stem cell research and have become a promising tool in the field of regenerative medicine ... See all stories on this topic »         Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes. December 31, 2010 at 7:04 AM   Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes. Diabetes. 2010 Dec;59(12):3139-47 Authors: Jurewicz M, Yang S, Augello A, Godwin JG, Moore RF, Azzi J, Fiorina P, Atkinson M, Sayegh MH, Abdi R A number of clinical trials are underway to test whether mesenchymal stem cells (MSCs) are effective in treating various diseases, including type 1 diabetes. Although this cell therapy holds great promise, the optimal source of MSCs has yet to be determined with respect to major histocompatibility complex matching. Here, we examine this question by testing the ability of congenic MSCs, obtained from the NOR mouse strain, to reverse recent-onset type 1 diabetes in NOD mice, as well as determine the immunomodulatory effects of NOR MSCs in vivo. PMID: 20841611 [PubMed - indexed for MEDLINE]         Local 'stem cell revolution' just getting its start December 31, 2010 at 6:10 AM   Robert Klein, chair of the governing board of California Institute for Regenerative Medicine, says stem cell research will accelerate jobs and therapies. ... See all stories on this topic » San Jose Business Journal             This email was sent to regenmd@gmail.com. Delivered by Feed My Inbox PO Box 682532 Franklin, TN 37068 Account Login Unsubscribe Here